Polygenic risk score for hypertrophic cardiomyopathy predicts population disease risk, penetrance in sarcomeric rare variant carriers and survival in cases
Event: ESC Congress 2023
Topic: Epidemiology, Prognosis, Outcome
Session: Young Investigator Awards Session in Heart Failure
Cardiovascular outcomes with the incretin-based therapies GLP-1 agonists and DPP-4 inhibitors in type 2 diabetes participants with and without heart failure
Event: Heart Failure 2018
Topic: Diabetes and the Heart
Session: Moderated Poster session 3 - Novel treatment
Effects of aliskiren on mortality, cardiovascular outcomes and adverse events in diabetics with cardiovascular disease or risk: a systematic review and meta-analysis of 13,395 patients
Event: ESC Congress 2017
Topic: Diabetes, dysglycaemia and metabolic syndrome
Session: Diabetes mellitus: from "omics to complications"
Reporting quality of randomised controlled trials investigating efficacy of pharmacological therapies for heart failure with preserved ejection fraction
Event: HEART FAILURE 2016
Topic: HFpEF - Heart failure with preserved ejection fraction
Session: HFpEF - Heart failure with preserved ejection fraction
ESC 365 is supported by
